EARLY DIAGNOSIS, PREVENTION AND TREATMENT OF CARDIOMETABOLIC AND NEURODEGENERATIVE DISEASES

Based in Lille (France) and Cambridge (MA, USA), Genfit was co-founded in 1999, by M. Jean-François Mouney, Chairman of the Management Board of Genfit, and Professor Bart Staels, President of the Scientific Advisory Board who have together many years of combined experience in both business and science. Today, Genfit is a European leader, and a renowned biopharmaceutical company.

Through its world-renowned scientific expertise, particularly in the field of nuclear receptors, Genfit’s research efforts are focused on the discovery and development of new treatments in the growing therapeutic areas of Cardiometabolic and Neurodegenerative disorders, such as prediabetes/diabetes, atherosclerosis, dyslipidemia, obesity, and Alzheimer’s. Genfit uses a multi-pronged approach based on early diagnosis, preventive solutions, and therapeutic treatments to address these major public health problems and their unmet medical needs.

The value of the company's drug discovery engine, which is supported by a team of about 120 people, has been validated by several pharmaceutical leaders such as Sanofi-Aventis, Solvay Group, and Servier Laboratories who have entrusted Genfit with a number of innovative research and drug development programs. In addition to generating revenue, these alliances conducted with pharmaceutical companies who have become long-term strategic partners and collaborators, have produced a strong project portfolio of first-in-class drug candidates and continue to push Genfit’s search engine as well as accelerate innovation.

Genfit's continuous track record of building incremental value through multiple routes is further strengthened by a solid patent portfolio, strong financial performance and resources and a diverse and rich proprietary pipeline of therapeutic products, tools and clinical biomarkers.

KEY FACTS

• Creation: 1999
• Employees: 120
• Location:
  • Headquartered in Lille (France)
  • Subsidiary in Cambridge (USA)
  • 7000m² state-of-the-art laboratories

GENFIT CORP.: AN INTERNATIONAL PRESENCE

Genfit is committed to partnering with academia, biotechnology and pharmaceutical companies worldwide. Genfit Corp., based in Cambridge (MA), is our local interface with leading institutes and companies in the North American marketplace. Our proximity to this world-renowned hub between the academic research community, leading hospitals and local biopharma firms offers many competitive advantages. The combination of technology and medicine makes this the perfect environment for therapeutic biotechnological innovation. Genfit Corp. participates in leading national pharma events, leveraging its strategic location and our scientific expertise to develop and expand academic and industry collaborative opportunities in the USA.

Download 2009 Corporate Fact Sheet